In the article cited above, there are typographical errors in Table 3 with regard to the values for hospitalization for heart failure results. The results should state an incidence of 2.7% (126/4,687) with empagliflozin and 4.1% (95/2,333) with placebo, and the corresponding incidence rates should be 9.4/1,000 patient-years and 14.5/1,000 patient-years, respectively. The HR of 0.65 (95% CI 0.50, 0.85) is correct.

The online version ( has been corrected to reflect these changes.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at